secwatch.observer — SEC 8-K summary
======================================

Issuer:     FibroBiologics, Inc. (FBLG)
CIK:        0001958777
Form:       8-K
Filed at:   2024-08-27T23:59:59+00:00
Accession:  0001493152-24-034006
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 3.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

FibroBiologics reports $3.9M gross proceeds from GEM equity line draw downs
---------------------------------------------------------------------------

- On Aug 26, 2024, sold 100,000 shares at net $4.51 (10% discount), gross $451K.
- Prior draw down: 840,000 shares at net $4.09, gross $3,436K; 560,000 shares returned for cancellation.
- Aggregate gross proceeds from GEM SPA subsequent to June 30, 2024: $3,887K.
- Remaining 1,500,000 shares from July 12 draw down returned to Company and cancelled.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1958777/000149315224034006/0001493152-24-034006-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1958777/000149315224034006/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-034006

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer